Interestingly, the fact that cinacalcet could restore diabetes-induced dysfunctions in an animal model and at a cellular level in HGECs and podocytes through the activation of AMPK suggests its therapeutic potential in the prevention and treatment of DN. The gene discussed is PRKAA2; the disease is liver dysplastic nodule.